NCT05251883Recruiting
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
Source: ClinicalTrials.gov · Last updated 19 May 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
As one of the most common malignant tumors in women, the incidence of ovarian cancer is expected to increase year by year. Due to its lack of typical symptoms and effective screening methods, and the characteristics of implantation and distant metastasis, more than 70% of ovarian cancers were in the metastatic stage at the time of diagnosis. In this study, the investigators will collect large samples of tissue from patients with ovarian cancer, conduct multi-omics studies, and mapped the characteristic maps of the genome and transcriptome of patients with metastatic ovarian cancer, and explore the molecular mechanisms that can be used as new targets for the treatment of ovarian cancer. Besides, the investigators will design and establish a database of metastatic ovarian cancer, integrate multiple omics, imaging, pathology, and clinical information to study their potential relevance, and analyze the relationship between various omics, imaging, pathology, and prognosis, establish ovaries Cancer prediction model.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 9 Jan 2022
- Start date
- 1 Jan 2022
- Primary completion date
- Dec 2023
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Diseases
- Ovarian cancer
- NCT number
- NCT05251883
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Jan 2022 to the primary completion date, Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have received other anti-tumor treatments or received tumor surgery before enrollment;
Other illness
- Patients with malignant tumors in other parts;
- Patients with uncontrollable neurological, psychiatric, or mental disorders;
Other
- Poor compliance and inability to Cooperate and describe treatment responders.
Who the study is looking for
- female, ≥18 years old;
- diagnosed as ovarian cancer by imaging and pathology;
- did not receive any anti-tumor drug treatment before surgery in the gynecology clinical department of the Sun Yat Sen Memorial Hospital of Sun Yat-Sen University;
- received ovarian cancer surgery and Follow-up treatment;
- Patients voluntarily participate in the research of this subject, have good compliance, and can complete the enrollment by the requirements of the trial;
- Sign informed consent and agree to the collection and use of their data.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit Coordinator of this site? Confirm its status | Guangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.